Tech Company Financing Transactions
Crux Biomedical Funding Round
Hercules Technology Growth Capital participated in a $250 thousand funding round for Crux Biomedical. The financing was announced on 10/4/2007.
Transaction Overview
Company Name
Announced On
10/4/2007
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors
Hercules Technology Growth Capital (Brandt Roberts)
Proceeds Purpose
"The equity from Hercules will support our pivotal U.S. clinical trials and pioneering R&D efforts," said Mel Schatz, CEO of Crux. "We expect to achieve a leadership position in this growing field by providing the easiest, most versatile IVC filter."
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1455 Adams Drive 1170
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
The company is developing a retrievable Inferior Vena Cava (IVC) filter that promises to be a great improvement over existing modes of treatment. The device has been successfully tested in animal studies in2006 and was recently implanted in humans. Crux is currently working with the FDA to design and implement large-scale human clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mel Schatz
Chief Financial Officer
Chris Schaffer
VP - Operations
Murli Srinivasan
VP - R & D
Eric Johnson
VP - Regulatory Affairs
Elisa Hebb
Browse more venture capital transactions:
Prev: 10/4/2007: APT Pharmaceuticals venture capital transaction
Next: 10/4/2007: Asoka venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs